Jazaeri AA - Search Results

1

SIO: A Spatioimageomics Pipeline to Identify Prognostic Biomarkers Associated with the Ovarian Tumor Microenvironment.

Zhu Y, Ferri-Borgogno S, Sheng J, Yeung TL, Burks JK, Cappello P, Jazaeri AA, Kim JH, Han GH, Birrer MJ, Mok SC, Wong STC. Zhu Y, et al. Among authors: jazaeri aa. Cancers (Basel). 2021 Apr 8;13(8):1777. doi: 10.3390/cancers13081777. Cancers (Basel). 2021. PMID: 33917869 Free PMC article.

2

Choice of normal ovarian control influences determination of differentially expressed genes in ovarian cancer expression profiling studies.

Zorn KK, Jazaeri AA, Awtrey CS, Gardner GJ, Mok SC, Boyd J, Birrer MJ. Zorn KK, et al. Among authors: jazaeri aa. Clin Cancer Res. 2003 Oct 15;9(13):4811-8. Clin Cancer Res. 2003. PMID: 14581352

3

Gene expression profiles associated with response to chemotherapy in epithelial ovarian cancers.

Jazaeri AA, Awtrey CS, Chandramouli GV, Chuang YE, Khan J, Sotiriou C, Aprelikova O, Yee CJ, Zorn KK, Birrer MJ, Barrett JC, Boyd J. Jazaeri AA, et al. Clin Cancer Res. 2005 Sep 1;11(17):6300-10. doi: 10.1158/1078-0432.CCR-04-2682. Clin Cancer Res. 2005. PMID: 16144934

4

Lymphocyte-specific kinase expression is a prognostic indicator in ovarian cancer and correlates with a prominent B cell transcriptional signature.

Hinchcliff E, Paquette C, Roszik J, Kelting S, Stoler MH, Mok SC, Yeung TL, Zhang Q, Yates M, Peng W, Hwu P, Jazaeri A. Hinchcliff E, et al. Cancer Immunol Immunother. 2019 Sep;68(9):1515-1526. doi: 10.1007/s00262-019-02385-x. Epub 2019 Sep 12. Cancer Immunol Immunother. 2019. PMID: 31515669 Free PMC article.

5

Phase II evaluation of nivolumab in the treatment of persistent or recurrent cervical cancer (NCT02257528/NRG-GY002).

Santin AD, Deng W, Frumovitz M, Buza N, Bellone S, Huh W, Khleif S, Lankes HA, Ratner ES, O'Cearbhaill RE, Jazaeri AA, Birrer M. Santin AD, et al. Among authors: jazaeri aa. Gynecol Oncol. 2020 Apr;157(1):161-166. doi: 10.1016/j.ygyno.2019.12.034. Epub 2020 Jan 7. Gynecol Oncol. 2020. PMID: 31924334 Free PMC article. Clinical Trial.

6

Molecular Analysis of Clinically Defined Subsets of High-Grade Serous Ovarian Cancer.

Lee S, Zhao L, Rojas C, Bateman NW, Yao H, Lara OD, Celestino J, Morgan MB, Nguyen TV, Conrads KA, Rangel KM, Dood RL, Hajek RA, Fawcett GL, Chu RA, Wilson K, Loffredo JL, Viollet C, Jazaeri AA, Dalgard CL, Mao X, Song X, Zhou M, Hood BL, Banskota N, Wilkerson MD, Te J, Soltis AR, Roman K, Dunn A, Cordover D, Eterovic AK, Liu J, Burks JK, Baggerly KA, Fleming ND, Lu KH, Westin SN, Coleman RL, Mills GB, Casablanca Y, Zhang J, Conrads TP, Maxwell GL, Futreal PA, Sood AK. Lee S, et al. Among authors: jazaeri aa. Cell Rep. 2020 Apr 14;31(2):107502. doi: 10.1016/j.celrep.2020.03.066. Cell Rep. 2020. PMID: 32294438 Free PMC article.

7

Modification of Homologous Recombination Deficiency Score Threshold and Association with Long-Term Survival in Epithelial Ovarian Cancer.

How JA, Jazaeri AA, Fellman B, Daniels MS, Penn S, Solimeno C, Yuan Y, Schmeler K, Lanchbury JS, Timms K, Lu KH, Yates MS. How JA, et al. Among authors: jazaeri aa. Cancers (Basel). 2021 Feb 24;13(5):946. doi: 10.3390/cancers13050946. Cancers (Basel). 2021. PMID: 33668244 Free PMC article.

8

Molecular Profiles of Serum-Derived Extracellular Vesicles in High-Grade Serous Ovarian Cancer.

Zhao L, Corvigno S, Ma S, Celestino J, Fleming ND, Hajek RA, Lankenau Ahumada A, Jennings NB, Thompson EJ, Tang H, Westin SN, Jazaeri AA, Zhang J, Futreal PA, Sood AK, Lee S. Zhao L, et al. Among authors: jazaeri aa. Cancers (Basel). 2022 Jul 23;14(15):3589. doi: 10.3390/cancers14153589. Cancers (Basel). 2022. PMID: 35892848 Free PMC article.

9

Expression of B7-H4 and IDO1 is associated with drug resistance and poor prognosis in high-grade serous ovarian carcinomas.

Niu N, Shen W, Zhong Y, Bast RC Jr, Jazaeri A, Sood AK, Liu J. Niu N, et al. Hum Pathol. 2021 Jul;113:20-27. doi: 10.1016/j.humpath.2021.04.003. Epub 2021 Apr 19. Hum Pathol. 2021. PMID: 33887301 Free PMC article.

10

Clinical Outcomes of Patients with Recurrent Microsatellite-Stable Endometrial Cancer in Early-Phase Immunotherapy Clinical Trials.

How JA, Jazaeri AA, Fu S, Rodon Ahnert J, Gong J, Stephen B, Ferreira Dalla Pria H, Bhosale P, Johnson A, Yuan Y, Meric-Bernstam F, Naing A. How JA, et al. Among authors: jazaeri aa. Cancers (Basel). 2022 Jul 29;14(15):3695. doi: 10.3390/cancers14153695. Cancers (Basel). 2022. PMID: 35954359 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

121 results

Search Page